Tesamorelin 5mg

£27.99

  • ≥99% Purity (HPLC)
  • Batch-tested & CoA available
  • For research use only

Tesamorelin is a stabilised 44-amino-acid GHRH analogue supplied lyophilised for controlled in-vitro studies of GHRH receptor signalling and GH-axis pathway modelling.

An N-terminal trans-3-hexenoyl group confers DPP-4 resistance, making this GHRH analogue a stable full-length comparator to the truncated GRF(1-29) reagents. For laboratory research only. Not for human use.

FOR LABORATORY RESEARCH USE ONLY

This product is supplied exclusively for scientific laboratory research. It is not intended for human or veterinary use or administration, therapeutic use, diagnostic use or clinical application.

Avanti Peptides does not provide advice regarding human administration, dosage, injection, reconstitution for administration, treatment protocols or therapeutic use.

Regulatory status

This product is sold as a laboratory research material and is not offered or promoted as a medicinal product. No therapeutic or medical claims are made for this product.

SKU: TESA-6MG Category:

Description

≥99% Purity (HPLC)
Batch-tested & CoA available
Lyophilised — stable at room temp
For research use only

About Tesamorelin

Tesamorelin is a stabilised 44-amino-acid analogue of human growth-hormone-releasing hormone, supplied as a lyophilised research compound. A trans-3-hexenoyl group on the N-terminus blocks dipeptidyl peptidase-4 cleavage, giving this GHRH analogue markedly longer stability in culture than unmodified GHRH(1-44).

Why researchers choose Avanti Peptides Tesamorelin: At 44 residues this is a demanding synthesis — the N-terminal acylation and full-length sequence are confirmed at release on every Tesamorelin lot.

Key features of Tesamorelin

  • Stabilised GHRH(1-44) analogue (44-amino-acid)
  • Sequence: trans-3-hexenoyl-Tyr-Ala-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Gly-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-Gln-Gln-Gly-Glu-Ser-Asn-Gln-Glu-Arg-Gly-Ala-Arg-Ala-Arg-Leu-NH₂ (44 amino acids)
  • Lyophilised solid — stable, easy to store, straightforward to reconstitute
  • Unit size: 5 mg / vial
  • Every batch released only after identity, purity, and appearance QC
  • Certificate of Analysis (CoA) and batch documentation available on request

Tesamorelin technical specifications

Product name Tesamorelin
Synonyms TH9507; trans-3-hexenoyl-GHRH(1-44) amide; Egrifta (reference nomenclature)
Amino-acid sequence trans-3-hexenoyl-Tyr-Ala-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Gly-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-Gln-Gln-Gly-Glu-Ser-Asn-Gln-Glu-Arg-Gly-Ala-Arg-Ala-Arg-Leu-NH₂
Class Stabilised GHRH(1-44) analogue (44-amino-acid)
Molecular formula C₂₂₁H₃₆₆N₇₂O₆₇S (free base)
Molecular weight ~5,135.9 g/mol
CAS number 218949-48-5
Purity ≥99% (HPLC)
Physical form Lyophilised powder
Appearance White to off-white solid
Unit size 5 mg / vial
Note N-terminal trans-3-hexenoyl group confers DPP-4 resistance

Reconstituting and storing Tesamorelin

  1. Before reconstitution: Store lyophilised vials at 2–8 °C, protected from light and moisture.
  2. Equilibrate: Allow vial and diluent to reach room temperature before opening.
  3. Reconstitute: Add Bacteriostatic Water (10 ml recommended). Swirl gently — do not vortex.
  4. After reconstitution: Store at 2–8 °C. Prepare aliquots to minimise freeze–thaw cycles.
  5. Compatibility: Use only within protocols that comply with your institution’s SOPs and local regulations.

Looking for complementary materials? See Bacteriostatic Water 10ml — recommended diluent, CJC-1295 (No DAC) 5mg — truncated GRF(1-29) comparator, Ipamorelin 5mg.

Tesamorelin in research

Researchers use Tesamorelin to probe GHRH receptor engagement and downstream signalling, including cAMP accumulation, PKA activation and associated transcriptional responses in somatotroph model systems. Because it retains the full 44-residue sequence rather than the truncated 1-29 fragment, this GHRH analogue is the closer structural comparator when benchmarking against native GHRH.

Synthesis and quality assurance

Avanti Peptides manufactures Tesamorelin via controlled, validated solid-phase peptide synthesis (SPPS) to deliver high purity and lot-to-lot consistency. Each batch undergoes identity verification, HPLC purity analysis (≥99%), and appearance inspection before release.

Frequently asked questions about Tesamorelin

What is Tesamorelin?
Tesamorelin is a 44-amino-acid peptide (sequence: trans-3-hexenoyl-Tyr-Ala-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Gly-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-Gln-Gln-Gly-Glu-Ser-Asn-Gln-Glu-Arg-Gly-Ala-Arg-Ala-Arg-Leu-NH₂). It is used exclusively for in-vitro laboratory research. See the product overview above for full context.
How should I store the peptide?
Store lyophilised vials at 2–8 °C, away from light and moisture. After reconstitution, keep at 2–8 °C and use aliquots to minimise freeze–thaw cycles.
What diluent should I use for reconstitution?
Most laboratories use Bacteriostatic Water (10 ml). Always follow your lab’s standard operating procedures (SOPs) for the specific assay.
Do you provide batch documentation / Certificate of Analysis?
Yes. Batch documentation including test results (CoA) is available on request. If it is not attached to your order confirmation, contact our support team and we will add it immediately.
Is this product intended for human use?
No. This material is strictly for laboratory research only and is not intended for human consumption, clinical application, or veterinary use.

Legal & safety notice

For research use only. Avanti Peptides supplies this material strictly for laboratory research. This product is not a medication, food supplement, or cosmetic and is not intended for human or veterinary use. By purchasing, you confirm that you are a qualified researcher and will handle the material in accordance with your institution’s policies and all applicable laws and regulations.

External resources for researchers